Article
AMO buys Pfizer's surgical ophthalmology unit
Advanced Medical Optics Inc. (AMO) brought something special to San Diegofor this week's American Society of Cataract and Refractive Surgery meeting-thesurgical ophthalmology business formerly owned by Pfizer. AMO and Pfizer on April 21 entered into a definitive agreement for AMO to acquire Pfizer's surgical ophthalmology business for $450 million in cash.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
